1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Home Sequential Compression Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Global Home Sequential Compression Devices Market Analysis and Forecasts, 2017 – 2031
5. Key Insights
5.1. Pricing Analysis
5.2. Epidemiology Of Venous Thromboembolism
5.3. COVID-19 Impact Analysis
6. Global Home Sequential Compression Devices Market Analysis and Forecasts, By Device Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Device Type, 2017 – 2031
6.3.1. Intermittent Pneumatic Compression (IPC) Devices
6.3.2. Lymphedema Pumps
6.3.3. Foot and Calf Compression Devices
6.3.4. Others
6.4. Market Attractiveness Analysis, By Device Type
7. Global Home Sequential Compression Devices Market Analysis and Forecasts, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017 – 2031
7.3.1. Deep Vein Thrombosis (DVT)
7.3.2. Venous Thromboembolism (VTE)
7.3.3. Pulmonary Embolus (PE)
7.3.4. Others
7.4. Market Attractiveness Analysis, By Application
8. Global Home Sequential Compression Devices Market Analysis and Forecasts, By Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Distribution Channel, 2017 – 2031
8.3.1. Retail Channels
8.3.2. Online Sales
8.4. Market Attractiveness Analysis, By Distribution Channel
9. Global Home Sequential Compression Devices Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, By Region
10. North America Home Sequential Compression Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Device Type, 2017 – 2031
10.2.1. Intermittent Pneumatic Compression (IPC) Devices
10.2.2. Lymphedema Pumps
10.2.3. Foot and Calf Compression Devices
10.2.4. Others
10.3. Market Value Forecast, by Application, 2017 – 2031
10.3.1. Deep Vein Thrombosis (DVT)
10.3.2. Venous Thromboembolism (VTE)
10.3.3. Pulmonary Embolus (PE)
10.3.4. Others
10.4. Market Value Forecast, by Distribution Channel, 2017 – 2031
10.4.1. Retail Channels
10.4.2. Online Sales
10.5. Market Value Forecast, by Country, 2017 – 2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Device Type
10.6.2. By Application
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Home Sequential Compression Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Device Type, 2017 – 2031
11.2.1. Intermittent Pneumatic Compression (IPC) Devices
11.2.2. Lymphedema Pumps
11.2.3. Foot and Calf Compression Devices
11.2.4. Others
11.3. Market Value Forecast, by Application, 2017 – 2031
11.3.1. Deep Vein Thrombosis (DVT)
11.3.2. Venous Thromboembolism (VTE)
11.3.3. Pulmonary Embolus (PE)
11.3.4. Others
11.4. Market Value Forecast, by Distribution Channel, 2017 – 2031
11.4.1. Retail Channels
11.4.2. Online Sales
11.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Device Type
11.6.2. By Application
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region
12. Asia Pacific Home Sequential Compression Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Device Type, 2017 – 2031
12.2.1. Intermittent Pneumatic Compression (IPC) Devices
12.2.2. Lymphedema Pumps
12.2.3. Foot and Calf Compression Devices
12.2.4. Others
12.3. Market Value Forecast, by Application, 2017 – 2031
12.3.1. Deep Vein Thrombosis (DVT)
12.3.2. Venous Thromboembolism (VTE)
12.3.3. Pulmonary Embolus (PE)
12.3.4. Others
12.4. Market Value Forecast, by Distribution Channel, 2017 – 2031
12.4.1. Retail Channels
12.4.2. Online Sales
12.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Device Type
12.6.2. By Application
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region
13. Latin America Home Sequential Compression Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Device Type, 2017 – 2031
13.2.1. Intermittent Pneumatic Compression (IPC) Devices
13.2.2. Lymphedema Pumps
13.2.3. Foot and Calf Compression Devices
13.2.4. Others
13.3. Market Value Forecast, by Application, 2017 – 2031
13.3.1. Deep Vein Thrombosis (DVT)
13.3.2. Venous Thromboembolism (VTE)
13.3.3. Pulmonary Embolus (PE)
13.3.4. Others
13.4. Market Value Forecast, by Distribution Channel, 2017 – 2031
13.4.1. Retail Channels
13.4.2. Online Sales
13.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Device Type
13.6.2. By Application
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region
14. Middle East & Africa Home Sequential Compression Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Device Type, 2017 – 2031
14.2.1. Intermittent Pneumatic Compression (IPC) Devices
14.2.2. Lymphedema Pumps
14.2.3. Foot and Calf Compression Devices
14.2.4. Others
14.3. Market Value Forecast, by Application, 2017 – 2031
14.3.1. Deep Vein Thrombosis (DVT)
14.3.2. Venous Thromboembolism (VTE)
14.3.3. Pulmonary Embolus (PE)
14.3.4. Others
14.4. Market Value Forecast, by Distribution Channel, 2017 – 2031
14.4.1. Retail Channels
14.4.2. Online Sales
14.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Device Type
14.6.2. By Application
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Global Home Sequential Compression Devices Market : Company Share Analysis (2022)
15.2. Company Profiles
15.2.1. Compression Solutions
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. Financial Overview
15.2.1.4. SWOT Analysis
15.2.1.5. Strategic Overview
15.2.2. AIROS Medical, Inc.
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. Financial Overview
15.2.2.4. SWOT Analysis
15.2.2.5. Strategic Overview
15.2.3. Lympha Press USA
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. Financial Overview
15.2.3.4. SWOT Analysis
15.2.3.5. Strategic Overview
15.2.4. Biocompression Systems
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Financial Overview
15.2.4.4. SWOT Analysis
15.2.4.5. Strategic Overview
15.2.5. Huntleigh Healthcare
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Financial Overview
15.2.5.4. SWOT Analysis
15.2.5.5. Strategic Overview
15.2.6. Globus Corporation
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. Financial Overview
15.2.6.4. SWOT Analysis
15.2.6.5. Strategic Overview
15.2.7. Fisiopress
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Financial Overview
15.2.7.4. SWOT Analysis
15.2.7.5. Strategic Overview
15.2.8. Welbutech
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. Financial Overview
15.2.8.4. SWOT Analysis
15.2.8.5. Strategic Overview
15.2.9. Devon Medical Products
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Product Portfolio
15.2.9.3. Financial Overview
15.2.9.4. SWOT Analysis
15.2.9.5. Strategic Overview
15.2.10. Tactile Medica
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Product Portfolio
15.2.10.3. Financial Overview
15.2.10.4. SWOT Analysis
15.2.10.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer